One of the side effects that some patients may experience is temporary blurred vision
96 participants were randomly assigned to groups of 6 multiple-ascending doses of once-weekly subcutaneous cagrilintide (final doses of 0.16, 0.30, 0.60, 1.2, 2.4, and 4.5 mg) in combination with once-weekly subcutaneous semaglutide 2.4 mg or semaglutide 2.4 mg with placebo for 20 weeks
-157 : , - MaxProtein Peptide Sciences
Kuroda M, Mimaki Y, Honda S, Tanaka H, Yokota S, Mae T
If you are curious about typical timelines, our article on how fast tirzepatide works breaks down the expectations